Learning and memory deficits after lesions of the nucleus basalis magnocellularis: reversal by physostigmine.
The role of the cholinergic nucleus basalis magnocellularis in spatial learning and memory was studied in the rat. Animals received bilateral injections of ibotenic acid (5 micrograms/microliters) into the region of the nucleus basalis magnocellularis. Six weeks postoperatively they were deprived of food and trained for 5 weeks in a 16-arm radial maze in which 9 of the arms were baited with food. The nucleus basalis magnocellularis-lesioned animals showed significant deficits in the acquisition of the task. Further analysis of the data indicated that this was due primarily to a deficit in reference (long-term) as opposed to working (short-term) memory. After the 5-week training period the nucleus basalis magnocellularis-lesioned animals received intraperitoneal injections of physostigmine sulphate (0.5 mg/kg) 30 min before each daily trial for 1 week. This treatment resulted in a significant improvement in the performance of the spatial memory task on all three measures. The ibotenate lesions reduced the activity of choline acetyltransferase by about 40% in the anterior cortex and by 15% in the posterior cortex. Hippocampal choline acetyltransferase activity was not affected, indicating that the septohippocampal cholinergic projection was spared by the lesions. The activity of glutamate decarboxylase was not affected in any of these regions. These results suggest that the cholinergic projections of the nucleus basalis magnocellularis play an important role in the acquisition of a spatial memory task.
D000818:Animals; D001479:Basal Ganglia / Q000502:physiology*; D001931:Brain Mapping; D002799:Cholinergic Fibers / Q000502:physiology; D007051:Ibotenic Acid / Q000494:pharmacology; D007858:Learning / Q000502:physiology*; D008568:Memory / Q000502:physiology*; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D012601:Scopolamine / Q000494:pharmacology; D013037:Spatial Behavior / Q000502:physiology; D013377:Substantia Innominata / Q000187:drug effects / Q000502:physiology*
D007051:Ibotenic Acid; D010830:Physostigmine; D012601:Scopolamine